Fujitsu develops multi-AI agent collaboration technology to optimise pharma supply chains
· Source: biospectrumasia.com
In short
Fujitsu Limited has developed a multi-AI agent collaboration technology to enable secure and swift collaboration among AI agents from different companies within a supply chain. Starting January 2026, it will be trialed with Rohto Pharmaceutical and Science Tokyo to optimize pharma supply chains, enhancing operational efficiency and resilience during emergencies. The technology aims to expand to broader industries to advance supply chain strategies and business sustainability.
Read Original Article — Read the full article on the publisher’s site.
In the issue of week 49, 2025: Agentic AI Orchestrates Supply Chains as Security and Governance Accelerate
Tags: pharma, supply chain, AI, collaboration, technology, resilience